Insmed | INSM - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Cytokinetics USD 9.6B 1.95B 2026-08
DBV Technologies USD 1.23B 327M 2026-03
Gilead Sciences USD 168.68B 11.82B 2026-08
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 19.68B 3.43B 2026-08
Novartis USD 288.26B 25.18B 2026-03
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Sarepta Therapeutics USD 1.5B 402M 2026-08
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08